Brief: Trevena Has Received Interest From Multiple Institutions Regarding Potential Studies That Could Evaluate Use Of Trv027 In Covid-19 Patients
18/05/2020 12:34
May 18 (Reuters) - Trevena Inc TRVN.O :
* TREVENA - HAS RECEIVED INTEREST FROM MULTIPLE INSTITUTIONS
REGARDING POTENTIAL STUDIES THAT COULD EVALUATE USE OF TRV027 IN
COVID-19 PATIENTS
Source text: [https://bit.ly/3cG4FRO]
Further company coverage: TRVN.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Trevena
See all newsTrevena Inc reports results for the quarter ended in June - Earnings Summary
Trevena Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Trevena Q2 EPS USD -0.23
Brief: Trevena Announces $2M Non-Dilutive Financing Tranche And Reduction In Outstanding Liabilities In Connection With Existing Ex-Us Royalty Financing
U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone